Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LOPINAVIR AND RITONAVIR

LOPINAVIR; RITONAVIR

Standard Dose
200MG;50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LOPINAVIR AND RITONAVIR is listed in Drugs@FDA under application 214696 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LOPINAVIR; RITONAVIR Form and strength TABLET;ORAL - 200MG;50MG Sponsor MICRO LABS Submission history Latest submission status date: 2025-12-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview LOPINAVIR AND RITONAVIR is listed in Drugs@FDA under application 214696 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LOPINAVIR; RITONAVIR Form and strength TABLET;ORAL - 200MG;50MG Sponsor MICRO LABS Submission history Latest submission status date: 2025-12-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.